Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;45(3):259-70.
doi: 10.1097/SHK.0000000000000473.

THE ENDOTHELIUM IN SEPSIS

Affiliations
Review

THE ENDOTHELIUM IN SEPSIS

Can Ince et al. Shock. 2016 Mar.

Abstract

Sepsis affects practically all aspects of endothelial cell (EC) function and is thought to be the key factor in the progression from sepsis to organ failure. Endothelial functions affected by sepsis include vasoregulation, barrier function, inflammation, and hemostasis. These are among other mechanisms often mediated by glycocalyx shedding, such as abnormal nitric oxide metabolism, up-regulation of reactive oxygen species generation due to down-regulation of endothelial-associated antioxidant defenses, transcellular communication, proteases, exposure of adhesion molecules, and activation of tissue factor. This review covers current insight in EC-associated hemostatic responses to sepsis and the EC response to inflammation. The endothelial cell lining is highly heterogeneous between different organ systems and consequently also in its response to sepsis. In this context, we discuss the response of the endothelial cell lining to sepsis in the kidney, liver, and lung. Finally, we discuss evidence as to whether the EC response to sepsis is adaptive or maladaptive. This study is a result of an Acute Dialysis Quality Initiative XIV Sepsis Workgroup meeting held in Bogota, Columbia, between October 12 and 15, 2014.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest: C.I. has received research grants the Dutch Kidney Foundation (grant C 09.2290 and grant 14OIP11), Bussum, The Netherlands. C.I. has also received honoraria and independent research grants from Fresenius-Kabi, Bad Homburg, Germany; Baxter Health Care, Deerfield, Illinois and AM-Pharma, Bunnik, The Netherlands. C.I. has developed SDF imaging and is listed as inventor on related patents commercialized by MicroVision Medical (MVM) under a license from the Academic Medical Center (AMC). C.I. has received consultant fees from MVM in the past, but has not been involved with this company for more than five years now, except that he still holds shares. Braedius Medical, a company owned by a relative of C.I., has developed and designed a hand-held microscope called Cyto-Cam-IDF imaging; however, C.I. has no financial relation with Braedius Medical of any sort. P.M., T.N., G.O., H.G., and G.H. have no declared interests. J.K. has received consulting fees from Abbott, Aethlon, Alere, Alung, AM Pharma, Astute Medical, Atox Bio, Baxter, Cytosorbents, venBio, Gambro, Grifols, Roche, Spectral Diagnostics, Sangart, and Siemens. J.K. has also received research grants from Alere, Astute Medical, Atox Bio, Bard, Baxter, Cytosorbents, Gambro, Grifols, Kaneka, and Spectral Diagnostics, and has licensed technologies through the University of Pittsburgh to Astute Medical, Cytosorbents, and Spectral Diagnostics. P.M. has received consulting fees from AM Pharma, Abbvie, FAST Diagnostics. He has also received research funding from Abbott, Alere, EKF Diagnostics. D.D.B. is a member of the Advisory Board Baxter-Gambro renal, and Nestlé Health Sciences. He received research grants and material for studies from Edwards Lifesciences, Vytech, and Imacor. P.M., T.N., G.O., H.G., and G.H. have no declared interests.

Figures

Fig. 1
Fig. 1. The endothelium in health
This figure shows a number of the key elements of the endothelium in health responsible for its key role in its interface between circulating blood and the parenchymal cells. Elements relating to it function as a vascular barrier, vascular regulation, transcellular signaling, and hemostasis are shown. Highlighted are the endothelium glycocalyx housing various molecules, including mechanotransducers (and its transducer role between sensing sheer stress and inducing NO affective for smooth muscle vasodilation, inactive adhesion molecules embedded in the glycocalyx, molecules essential for hemostatic, and antioxidant defense molecules such as SOD). Intra and transcellular elements of the endothelial shown include mitochondria, with its contribution to ROS generation and oxidative phosphorylation. Transcellular elements present include gap junctions for electrical communication for upstream vascular regulation and intercellular tight junctions important for maintaining vascular barrier. Morphological elements shown include transcellular fenestrations and pores. Source: Acute Dialysis Quality Initiative 14, www.ADQI.net 2014; used with permission.
Fig. 2
Fig. 2. The endothelium in sepsis
This figure shows the pathogenic effect of sepsis on the various elements of the ECL resulting in its functional impairment in terms of its function as a vascular barrier, a regulator of vasotone, and its hemostatic function. The destruction of the glycocalyx results, among many other effects, in the exposure of adhesion molecules, resulting in the trapping (selectins) and transmigration (integrins) of activated leukocytes, activation of hemostatic compounds in favor of a proprocoagulant state, and the loss of mechanotransducer function due to these molecules, losing their natural environment essential for the sensing of sheer stress. The barrier function of the ECL is compromised by direct membrane destruction due to lipid peroxidation induced by ROS/RNS, as well as the decomposition of molecules such as tight junctions anchoring the EC together. The role of the EC as a vasomotor tone regular is lost due to the loss of function of the mechanotransducer system, the overproduction of iNOS-mediated NO, and the loss of transcellular gap junction essential for an integrative control of vasotone along the ECL. Endothelial destruction also results in the release of microparticles contributing to the pathogenic effect of EC dysfunction. Source: Acute Dialysis Quality Initiative 14, www.ADQI.net 2014; used with permission. iNOS indicates inducible nitric oxide synthase; RNS, reactive nitrogen species.
Fig. 3
Fig. 3. Adaptive versus maladaptive response to sepsis
Source: Acute Dialysis Quality Initiative 14, www.ADQI.net 2014; used with permission.

References

    1. Ait-Oufella H, Maury E, Lehoux S, Guidet B, Offenstadt G. The endothelium: physiological functions and role in microcirculatory failure during severe sepsis. Intensive Care Med. 2010;36:1286–1298. - PubMed
    1. Kellum JA, Gómez H, Gómez A, Murray P, Ronco C. Acute Dialysis Quality Initiative (ADQI) XIV sepsis phenotypes and targets for blood purification in sepsis: The Bogota Consensus. Shock. 2016;45:242–248. - PubMed
    1. Aird WC. Endothelial cell heterogeneity. Cold Spring Harb Perspect Med. 2012;2:a006429. - PMC - PubMed
    1. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121–167. - PubMed
    1. Zuurbier C, Vink H, Koeman A, Demirci C, Ince C. Short-term hyperglycemia increases endothelial glycocalyx permeability and decreases lineal density of capillaries with flowing RBC’s. J Appl Physiol. 2005;99:1471–1476. - PubMed

Publication types